GCL
OACC

Glazer Capital LLC’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Glazer Capital LLC’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.83M Sell
357,649
-273
-0.1% -$2.91K 0.09% 200
2026
Q1 		$3.79M Sell
357,922
-7,178
-2% -$76.4K 0.08% 197
2025
Q4 		$3.86M Hold
365,100
– – 0.1% 152
2025
Q3 		$3.84M Hold
365,100
– – 0.13% 134
2025
Q2 		$3.81M Sell
365,100
-22,497
-6% -$233K 0.14% 100
2025
Q1 		$3.96M Buy
+387,597
New +$3.89M 0.18% 76

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.37B AUM 26.91% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BGGS
Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Glazer Capital LLC's OACC Position: Q2 2026 in Review

Glazer Capital LLC reduced its Oaktree Acquisition Corp III Life Sciences (OACC) stake by 0.08% in Q2 2026, selling an estimated $2.91K and leaving 357,649 shares worth $3.83M. The position accounts for 0.09% of the portfolio, ranked #200.

Glazer Capital LLC first reported a position in OACC in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.96M in Q1 2025. 50 funds tracked by Wall St. Rank hold OACC as of Q2 2026.

  • Glazer Capital LLC held 357,649 shares of Oaktree Acquisition Corp III Life Sciences worth $3.83M as of Q2 2026.
  • Glazer Capital LLC sold 273 Oaktree Acquisition Corp III Life Sciences shares in Q2 2026, an estimated $2.91K.
  • Oaktree Acquisition Corp III Life Sciences made up 0.09% of Glazer Capital LLC's portfolio in Q2 2026, its #200 holding.
  • Glazer Capital LLC first reported a position in Oaktree Acquisition Corp III Life Sciences in Q1 2025 and has held it in 6 quarters since.
  • Glazer Capital LLC's Oaktree Acquisition Corp III Life Sciences position peaked at $3.96M in Q1 2025.
  • 50 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q2 2026.

Based on Glazer Capital LLC's 13F filing for Q2 2026, filed 17 Aug 2026.